Stanley-Laman Group’s Prestige Consumer Healthcare PBH Stock Holding History

Stanley-Laman Group’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-65,499	Closed	-$3.28M	–	288
2017 Q3	$3.28M	Buy	65,499 +7,394	+13%	+$378K	0.88%	38
2017 Q2	$3.07M	Sell	58,105 -2,372	-4%	-$127K	0.83%	38
2017 Q1	$3.36M	Buy	60,477 +3,584	+6%	+$198K	0.91%	33
2016 Q4	$2.96M	Buy	56,893 +35,112	+161%	+$1.69M	0.92%	17
2016 Q3	$1.05M	Buy	21,781 +3,515	+19%	+$178K	0.43%	77
2016 Q2	$1.01M	Buy	+18,266	New	+$1.01M	0.4%	80

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MRCP

Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Stanley-Laman Group's PBH Position: Q4 2017 in Review

Stanley-Laman Group sold out of Prestige Consumer Healthcare (PBH) in Q4 2017, closing a stake of 65,499 shares — an estimated $3.28M sold.

Stanley-Laman Group first reported a position in PBH in Q2 2016 and held it in 6 quarters. The position peaked at $3.36M in Q1 2017. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

Stanley-Laman Group reported no remaining Prestige Consumer Healthcare position as of Q4 2017 after selling out during the quarter.
Stanley-Laman Group sold 65,499 Prestige Consumer Healthcare shares in Q4 2017, an estimated $3.28M.
Stanley-Laman Group first reported a position in Prestige Consumer Healthcare in Q2 2016 and held it in 6 quarters.
Stanley-Laman Group's Prestige Consumer Healthcare position peaked at $3.36M in Q1 2017.
251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Stanley-Laman Group's 13F filing for Q4 2017, filed 9 Feb 2018.